Crossmark

Unveiling tumor-infiltrating immune cell-driven immune-mediated drug resistance in clear cell renal cell carcinoma: prognostic insights and therapeutic strategies

Crossref DOI link: https://doi.org/10.1007/s12672-025-01890-z

Published Online: 2025-03-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yang, Jifeng

Xing, Yixuan

Luan, Jiusong

Yang, Wenbo

Zhang, Xin

Tian, Yanhua

Zhang, Haisong
Funding

Funding for this research was provided by:

Scientific Research Project of Hebei Provincial Health Commission (ZF2023235)
License Information

Text and Data Mining valid from 2025-03-01

Version of Record valid from 2025-03-01
More Information

Article History

Received: 30 November 2024

Accepted: 3 February 2025

First Online: 1 March 2025

Declarations

:

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below